Literature DB >> 17168305

[Research progress in SELDI-TOF MS and its clinical applications].

William Chi-shing Cho1.   

Abstract

Proteinchip profiling is a powerful and innovative proteomic technology for biomarker discovery and diagnostic/prognostic assay development. Based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS), Ciphergen's proteinchip system offers a single, unified, high-throughput platform for a multitude of proteomic research applications. Proteins are the major functional components of the cell, the study of proteomics provides mankind with a better understanding of disease and life. The remarkable findings in disease biomarkers have shed light to the early diagnosis, monitoring and predicting prognosis of various diseases, especially for cancer. In this article, the development and technology of SELDI-TOF MS are introduced. Some research progress and encouraging research results in oncoproteomics, infectious diseases, neurological diseases and diabetes mellitus using SELDI-TOF MS are also reviewed. The paper is closed by the appraisals on its pros and cons, as well as the future prospective is also expounded.

Entities:  

Mesh:

Year:  2006        PMID: 17168305      PMCID: PMC7148935          DOI: 10.1016/s1872-2075(06)60061-7

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  44 in total

1.  Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics.

Authors:  Ali Bouamrani; Jessica Ternier; David Ratel; Alim-Louis Benabid; Jean-Paul Issartel; Elisabeth Brambilla; François Berger
Journal:  Clin Chem       Date:  2006-09-21       Impact factor: 8.327

2.  Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS.

Authors:  William C S Cho; Tai-Tung Yip; Wai-Shing Chung; Sally K W Lee; Albert W N Leung; Christopher H K Cheng; Kevin K M Yue
Journal:  J Ethnopharmacol       Date:  2006-05-20       Impact factor: 4.360

3.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

Review 4.  SELDI-TOF proteomic analysis and cancer detection.

Authors:  N A Henderson; R J C Steele
Journal:  Surgeon       Date:  2005-12       Impact factor: 2.392

5.  Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.

Authors:  William C S Cho; Timothy T C Yip; Christine Yip; Victor Yip; Vanitha Thulasiraman; Roger K C Ngan; Tai-Tung Yip; Wai-Hon Lau; Joseph S K Au; Stephen C K Law; Wai-Wai Cheng; Victor W S Ma; Cadmon K P Lim
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

6.  Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Authors:  Bao-Ling Adam; Yinsheng Qu; John W Davis; Michael D Ward; Mary Ann Clements; Lisa H Cazares; O John Semmes; Paul F Schellhammer; Yutaka Yasui; Ziding Feng; George L Wright
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

7.  [Diagnostic value of the morphological ultrasound score system and the serum concentration of CA 125 in the diagnosis of malignant ovarian cancer].

Authors:  Jacek Brazert; Marek Pietryga; Waldemar Szabłoński; Aleksandra Persona-Sliwińska; Romuald Biczysko
Journal:  Ginekol Pol       Date:  2003-12       Impact factor: 1.232

8.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer.

Authors:  P H Gann; C H Hennekens; M J Stampfer
Journal:  JAMA       Date:  1995-01-25       Impact factor: 56.272

9.  Application of serum SELDI proteomic patterns in diagnosis of lung cancer.

Authors:  Shuan-ying Yang; Xue-yuan Xiao; Wang-gang Zhang; Li-juan Zhang; Wei Zhang; Bin Zhou; Guoan Chen; Da-cheng He
Journal:  BMC Cancer       Date:  2005-07-20       Impact factor: 4.430

View more
  14 in total

1.  New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Renyong Guo; Chunqin Pan; Jianmin Shen; Chibo Liu
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-21       Impact factor: 4.553

2.  Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma.

Authors:  Chibo Liu; Chunqin Pan; Yong Liang
Journal:  Exp Ther Med       Date:  2012-03-14       Impact factor: 2.447

3.  Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma.

Authors:  Chibo Liu; Chunqin Pan; Haibao Wang; Liang Yong
Journal:  Tumour Biol       Date:  2011-08-09

4.  Identification of serum amyloid A in the serum of gastric cancer patients by protein expression profiling.

Authors:  Chibo Liu; Chunqin Pan; Jianmin Shen; Haibao Wang; Liang Yong
Journal:  Oncol Lett       Date:  2012-03-30       Impact factor: 2.967

5.  Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Authors:  Yoshio Araki; Kazuhiro Yoshikawa; Sho Okamoto; Masaki Sumitomo; Mikio Maruwaka; Toshihiko Wakabayashi
Journal:  BMC Neurol       Date:  2010-11-08       Impact factor: 2.474

6.  A classification method based on principal components of SELDI spectra to diagnose of lung adenocarcinoma.

Authors:  Qiang Lin; Qianqian Peng; Feng Yao; Xu-Feng Pan; Li-Wen Xiong; Yi Wang; Jun-Feng Geng; Jiu-Xian Feng; Bao-Hui Han; Guo-Liang Bao; Yu Yang; Xiaotian Wang; Li Jin; Wensheng Guo; Jiu-Cun Wang
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

7.  Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.

Authors:  Faiz-Ul-Hassan Nasim; Samina Ejaz; Muhammad Ashraf; Abdul Rehman Asif; Michael Oellerich; Gulzar Ahmad; Gulzar Ahmad Malik
Journal:  Biomark Cancer       Date:  2012-12-10

8.  Reproducible cancer biomarker discovery in SELDI-TOF MS using different pre-processing algorithms.

Authors:  Jinfeng Zou; Guini Hong; Xinwu Guo; Lin Zhang; Chen Yao; Jing Wang; Zheng Guo
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

9.  MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.

Authors:  Chibo Liu; Chunqin Pan; Jianmin Shen; Haibao Wang; Liang Yong
Journal:  Int J Med Sci       Date:  2011-01-03       Impact factor: 3.738

Review 10.  Contribution of oncoproteomics to cancer biomarker discovery.

Authors:  William C S Cho
Journal:  Mol Cancer       Date:  2007-04-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.